论文部分内容阅读
目的:比较伐昔洛韦与阿昔洛韦治疗带状疱疹的疗效。方法:将研究对象随机分为对照组和观察组,对照组口服阿昔洛韦,观察组口服伐昔洛韦,连续治疗10天,观察2组治疗效果及不良反应。结果:对照组9例(30.0%)痊愈,8例(26.7%)显效,12例(40.0%)有效,1例(3.3%)无效;观察组23例(76.7%)痊愈,4例(13.3%)显效,3例(10.0%)有效,0例无效,观察组治疗效果明显优于对照组(p<0.05);治疗期间出现的不良反应不影响治疗进程,且差异无统计学意义(p>0.05)。结论:伐昔洛韦比阿昔洛韦更能有效地治疗带状疱疹。
Objective: To compare the efficacy of valacyclovir and acyclovir in the treatment of shingles. Methods: The subjects were randomly divided into control group and observation group, the control group oral acyclovir, the observation group oral valacyclovir, continuous treatment for 10 days, the observation group 2 treatment and adverse reactions. Results: In the control group, 9 cases (30.0%) were cured, 8 cases (26.7%) were effective, 12 cases (40.0%) were effective and 1 case %), 3 cases (10.0%) were effective, 0 cases were ineffective, the treatment group was significantly better than the control group (p <0.05); adverse reactions during treatment did not affect the course of treatment, and the difference was not statistically significant > 0.05). Conclusion: Valacyclovir is more effective than acyclovir in the treatment of shingles.